{"id":"W4400174824","doi":"10.1080/09546634.2024.2371045","title":"Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Placebo; Psoriasis; Apremilast; Plaque psoriasis; Onset of action; Internal medicine; Clinical trial; Randomized controlled trial; Gastroenterology; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002604702,0.0006988019,0.001439513,0.0002695812,0.0003647604,0.0008837015,0.0005083791,0.0007871737,0.002300992],"category_scores_gemma":[0.00146757,0.0002240484,0.001359465,0.0003024839,0.0003207199,0.0005280423,0.0002641044,0.001653875,0.0003372039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007345154,"about_ca_system_score_gemma":0.0008181242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004929975,"about_ca_topic_score_gemma":0.001736528,"domain_scores_codex":[0.9990344,0.0005577098,0.0000591124,0.0001180935,0.000105723,0.0001250379],"domain_scores_gemma":[0.9990976,0.000218448,0.0003520155,0.00005453134,0.00008041727,0.0001970093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6450291,0.01181452,0.01205382,0.004426422,0.004491204,0.0002513741,0.0003065132,0.003656144,0.03784363,0.0005276906,0.007640261,0.2719594],"study_design_scores_gemma":[0.5934595,0.2976166,0.07166254,0.0004474509,0.003373326,0.001450027,0.0001314289,0.002834464,0.01365898,0.0008870405,0.0143857,0.00009291765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.965498,0.02576479,0.0006937981,0.0005805126,0.0001275064,0.001649682,0.0009083287,0.0001616293,0.004615703],"genre_scores_gemma":[0.9910305,0.004386267,0.0008986875,0.0004347715,0.0001148502,0.001009471,0.0009163766,0.00001822195,0.00119084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002604702,"threshold_uncertainty_score":0.01377517,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08820321456382156,"score_gpt":0.3608091798270552,"score_spread":0.2726059652632336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}